Consolidated Biosciences ApS — Credit Rating and Financial Key Figures

CVR number: 40180230
Fredheimvej 9, 2950 Vedbæk

Income statement (kDKK)

2020
2021
2022
2023
2024
Fiscal period length1212121212
Net sales
Gross profit-43.00-33.75-45.63-54.38-49.13
EBIT-43.00-33.75-45.63-54.38-49.13
Other financial expenses-1 240.02-2 320.00-3 154.56-4 331.27-5 220.00
Net income from associates (fin.)686.301 218.361 922.602 835.893 393.15
Pre-tax profit- 596.72-1 135.39-1 277.58-1 549.75-1 875.98
Income taxes11.9949.18275.37- 169.59135.68
Net earnings- 584.73-1 086.21-1 002.21-1 719.34-1 740.30

Assets (kDKK)

2020
2021
2022
2023
2024
Intangible assets total
Tangible assets total
Holdings in group member companies27 719.9927 719.99
Participating interests22 500.0022 500.0027 719.99
Investments total22 500.0022 500.0027 719.9927 719.9927 719.99
Non-curr. owed by group member comp.43 827.2670 663.1584 056.30
Non-curr. owed by particip. interest comp.15 686.3029 904.66
Long term receivables total15 686.3029 904.6643 827.2670 663.1584 056.30
Inventories total
Current deferred tax assets30.8033.00274.4755.0077.00
Short term receivables total30.8033.00274.4755.0077.00
Balance sheet total (assets)38 217.1052 437.6671 821.7298 438.14111 853.29

Equity and liabilities (kDKK)

2020
2021
2022
2023
2024
Share capital50.0050.0050.0050.0050.00
Retained earnings600.1515.423 929.202 926.993 707.65
Profit of the financial year- 584.73-1 086.21-1 002.21-1 719.34-1 740.30
Shareholders equity total65.42-1 020.792 976.991 257.652 017.35
Non-current owed to group member38 125.4353 430.9568 814.7297 140.49109 794.32
Non-current liabilities total38 125.4353 430.9568 814.7297 140.49109 794.32
Other non-interest bearing current liabilities26.2527.5030.0040.0041.63
Current liabilities total26.2527.5030.0040.0041.63
Balance sheet total (liabilities)38 217.1052 437.6671 821.7298 438.14111 853.29
Try the full version of our system for free
Bankruptcy risk visualization example

... and more!

No registration needed.